CANTOURAGE GROUP SE (HIGH.DE) Stock Price, Forecast & Analysis

FRA:HIGH • DE000A3DSV01

4.3 EUR
+0.22 (+5.39%)
Last: Feb 25, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership

HIGH.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap51.08M
Revenue(TTM)N/A
Net Income(TTM)N/A
Shares11.88M
Float11.88M
52 Week High6.76
52 Week Low2.32
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2022-10-11
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
HIGH.DE short term performance overview.The bars show the price performance of HIGH.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30 40

HIGH.DE long term performance overview.The bars show the price performance of HIGH.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of HIGH.DE is 4.3 EUR. In the past month the price increased by 14.36%. In the past year, price decreased by -9.66%.

CANTOURAGE GROUP SE / HIGH Daily stock chart

HIGH.DE Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to HIGH.DE. When comparing the yearly performance of all stocks, HIGH.DE is one of the better performing stocks in the market, outperforming 77.16% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
HIGH.DE Full Technical Analysis Report

HIGH.DE Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A
HIGH.DE financials

HIGH.DE Forecast & Estimates

8 analysts have analysed HIGH.DE and the average price target is 8.41 EUR. This implies a price increase of 95.7% is expected in the next year compared to the current price of 4.3.


Analysts
Analysts85
Price Target8.41 (95.58%)
EPS Next YN/A
Revenue Next YearN/A
HIGH.DE Analyst EstimatesHIGH.DE Analyst Ratings

HIGH.DE Ownership

Ownership
Inst Owners1.19%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
HIGH.DE Ownership

HIGH.DE Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
SAN SANOFI9.57195.131B
SNW SANOFI9.55194.913B
1SAN SANOFI9.54194.744B
1MRK MERCK KGAA14.9255.76B
MRK MERCK KGAA14.6254.695B
UNC UCB SA26.3452.693B
UCB UCB SA24.1552.459B
1BAYN BAYER AG-REG8.7541.984B
BAYN BAYER AG-REG8.5741.836B
IPN IPSEN14.0713.359B

Related stock screener links

View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges

About HIGH.DE

Company Profile

HIGH logo image Cantourage Group SE is a holding company that engages in the cultivation and production of medicinal cannabis. The company is headquartered in Berlin, Berlin and currently employs 7 full-time employees. The company went IPO on 2022-10-11. The firm is engaged in the production and distribution of medical cannabis. The company is engaged in market segments as: dried flowers, extracts, Dronabinol and pharma-grade Cannabidiol, through Cantourage GmbH and its subsidiaries. Cantourage GmbH, one of the subsidiaries, is engaged in the production and wholesale trade of cannabis-based medicinal preparations, as well as the trade of other cannabis products.

Company Info

CANTOURAGE GROUP SE

Feurigstrasse 54

Berlin BERLIN DE

Employees: 7

HIGH Company Website

HIGH Investor Relations

Phone: 4930470135050

CANTOURAGE GROUP SE / HIGH.DE FAQ

Can you describe the business of CANTOURAGE GROUP SE?

Cantourage Group SE is a holding company that engages in the cultivation and production of medicinal cannabis. The company is headquartered in Berlin, Berlin and currently employs 7 full-time employees. The company went IPO on 2022-10-11. The firm is engaged in the production and distribution of medical cannabis. The company is engaged in market segments as: dried flowers, extracts, Dronabinol and pharma-grade Cannabidiol, through Cantourage GmbH and its subsidiaries. Cantourage GmbH, one of the subsidiaries, is engaged in the production and wholesale trade of cannabis-based medicinal preparations, as well as the trade of other cannabis products.


What is the current price of HIGH stock?

The current stock price of HIGH.DE is 4.3 EUR. The price increased by 5.39% in the last trading session.


Does HIGH stock pay dividends?

HIGH.DE does not pay a dividend.


What is the ChartMill technical and fundamental rating of HIGH stock?

HIGH.DE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


On which exchange is HIGH.DE stock listed?

HIGH.DE stock is listed on the Frankfurt Stock Exchange exchange.


What is the market capitalization of HIGH stock?

CANTOURAGE GROUP SE (HIGH.DE) has a market capitalization of 51.08M EUR. This makes HIGH.DE a Micro Cap stock.